Drug Type Small molecule drug |
Synonyms |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis 11 | Phase 1 | United States | 09 Oct 2022 | |
Attention Deficit Disorder With Hyperactivity | Phase 1 | United States | 09 Oct 2022 | |
Chronic Traumatic Encephalopathy | Phase 1 | United States | 09 Oct 2022 | |
Epilepsy | Phase 1 | United States | 09 Oct 2022 | |
Multiple Sclerosis | Phase 1 | United States | 09 Oct 2022 | |
Parkinson Disease | Phase 1 | United States | 09 Oct 2022 | |
Schizophrenia | Phase 1 | United States | 09 Oct 2022 | |
Migraine Disorders | Phase 1 | - | 01 Oct 2022 |